Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IB/II Study of Enzalutamide With Ribociclib in mCRPC
NCT02555189Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Dec 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Dec 2015; status: terminated.
02
Drugs
ribociclib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02555189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555189.